ACA
Atlas Capital Advisors Portfolio holdings
AUM
$819M
This Quarter Return
-11.35%
1 Year Return
+20%
3 Year Return
+70.15%
5 Year Return
+108.54%
10 Year Return
–
AUM
$250M
AUM Growth
+$250M
(-17%)
Cap. Flow
-$99.5M
Cap. Flow
% of AUM
-39.87%
Top 10 Holdings %
Top 10 Hldgs %
19.69%
Holding
625
New
89
Increased
123
Reduced
203
Closed
64
Top Buys
| 1 |
Pfizer
PFE
|
$1.4M |
| 2 |
Johnson & Johnson
JNJ
|
$1.37M |
| 3 |
CVS Health
CVS
|
$1.34M |
| 4 |
Vanguard Health Care ETF
VHT
|
$1.33M |
| 5 |
Vanguard FTSE Pacific ETF
VPL
|
$1.3M |
Top Sells
| 1 |
Berkshire Hathaway Class A
BRK.A
|
$90.9M |
| 2 |
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
|
$2.08M |
| 3 |
Vanguard Communication Services ETF
VOX
|
$1.39M |
| 4 |
Vanguard Small-Cap Value ETF
VBR
|
$1.21M |
| 5 |
Vanguard Mid-Cap Value ETF
VOE
|
$1.17M |
Sector Composition
| 1 | Healthcare | 11.19% |
| 2 | Technology | 8.93% |
| 3 | Financials | 8.92% |
| 4 | Consumer Staples | 7.16% |
| 5 | Consumer Discretionary | 5.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
RTX Corp
RTX
$212B
| $639K | 0.26% |
6,000
| – | – |
|
102
Labcorp
LH
$22.8B
| $633K | 0.25% |
5,012
+1,781
| +55% | +$225K |
|
103
Vale
VALE
$43.6B
| $623K | 0.25% |
47,238
+7,096
| +18% | +$93.6K |
|
104
JPMorgan Chase
JPM
$824B
| $620K | 0.25% |
6,349
-944
| -13% | -$92.2K |
|
|
CEO
105
DELISTED
CNOOC Limited
CEO
| $618K | 0.25% |
4,051
-135
| -3% | -$20.6K |
|
106
Energy Select Sector SPDR Fund
XLE
$27.1B
| $616K | 0.25% |
10,746
+7,083
| +193% | +$406K |
|
107
Vanguard Energy ETF
VDE
$7.28B
| $607K | 0.24% |
7,871
-3,489
| -31% | -$269K |
|
108
Schwab US REIT ETF
SCHH
$8.24B
| $605K | 0.24% |
15,712
+8,076
| +106% | +$311K |
|
109
NVIDIA
NVDA
$4.15T
| $604K | 0.24% |
4,521
-449
| -9% | -$59.9K |
|
110
Adobe
ADBE
$148B
| $593K | 0.24% |
2,620
-108
| -4% | -$24.4K |
|
111
NRG Energy
NRG
$28.4B
| $565K | 0.23% |
14,267
-103
| -0.7% | -$4.08K |
|
112
Vanguard Utilities ETF
VPU
$7.23B
| $559K | 0.22% |
4,746
+1,872
| +65% | +$221K |
|
|
IDTI
113
DELISTED
Integrated Device Technology I
IDTI
| $555K | 0.22% |
+11,456
| New | +$555K |
|
114
Novartis
NVS
$248B
| $549K | 0.22% |
6,399
+2,399
| +60% | +$206K |
|
115
Abbott
ABT
$230B
| $549K | 0.22% |
7,588
| – | – |
|
116
Pacific Biosciences
PACB
$378M
| $547K | 0.22% |
+73,950
| New | +$547K |
|
117
Credicorp
BAP
$20.8B
| $547K | 0.22% |
2,466
-43
| -2% | -$9.53K |
|
118
Quest Diagnostics
DGX
$20.1B
| $540K | 0.22% |
6,481
-362
| -5% | -$30.1K |
|
119
Tyson Foods
TSN
$20B
| $538K | 0.22% |
10,074
| – | – |
|
120
Banco Bradesco
BBD
$31.9B
| $536K | 0.21% |
+54,147
| New | +$536K |
|
|
ATHN
121
DELISTED
Athenahealth, Inc.
ATHN
| $534K | 0.21% |
4,045
-683
| -14% | -$90.1K |
|
122
General Mills
GIS
$26.6B
| $532K | 0.21% |
+13,661
| New | +$532K |
|
123
Southwest Airlines
LUV
$17B
| $531K | 0.21% |
11,423
-1,397
| -11% | -$64.9K |
|
124
Baxter International
BAX
$12.1B
| $522K | 0.21% |
7,932
| – | – |
|
|
CHL
125
DELISTED
China Mobile Limited
CHL
| $520K | 0.21% |
10,828
-5,481
| -34% | -$263K |
|